News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yousef Zakharia: Combining hypomethylating agent guadecitabine and IO in ccRCC
Photo taken from: Yousef Zakharia/X
Feb 2, 2024, 12:11

Yousef Zakharia: Combining hypomethylating agent guadecitabine and IO in ccRCC

Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post on X:

“Thrilled to share our clinical trial conducted though Big Ten Cancer Research Consortium in Nature Communications combining hypomethylating agent guadecitabine and IO in ccRCC. Huge team effort in conducting and publishing this IIT.”

Read further.
Source: Yousef Zakharia/X

Big Ten Cancer Research Consortium cancer Nature Communications OncoDaily Oncology Research Yousef Zakharia
Special Coverage
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Career
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA's Center for Biologics Evaluation and Research
Blog
May 9, 2025, 06:47
Wade Swenson: Addressing the rural cancer care crisis in Minnesota requires innovative solutions
Oncolibrary
May 9, 2025, 06:27
Understanding Neoplasms: What They Are, Types, Causes, and How They’re Treated
Insight
May 9, 2025, 06:07
Oguna Kasam: Landmark Achievement for Kenya - Aga Khan University Hospital Delivered First Lutetium 177 Therapy
Drugs
May 9, 2025, 05:39
Erika Hamilton: Zanidatamab Combination Shows Promising Results in HR+/HER2+ Metastatic Breast Cancer
Science
May 9, 2025, 04:20
Valerie Yang: What started out as an academic collaboration is now available as a treatment option for soft tissue sarcoma patients